Evidence map›Paper›PMID 42663072›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

Analysis of minimum inhibitory concentrations of azithromycin, ceftriaxone and ciprofloxacin for

Lena Böff, Kathleen Klaper, Achim Dörre, Annemarie Pantke, Susanne Buder, Sandra Dudareva, Viviane Bremer, Dagmar Heuer, Klaus Jansen, Regina Selb and 1 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lena BöffDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Kathleen KlaperDepartment for Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Achim DörreDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Annemarie PantkeDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Susanne BuderDepartment for Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Sandra DudarevaDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Viviane BremerDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Dagmar HeuerDepartment for Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Klaus JansenDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Regina SelbDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Go-Surv-AMR study groupThe members of the Go-Surv-AMR study group are listed under Collaborators.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND

Indexed as

Anti-Bacterial AgentsAzithromycinCeftriaxoneCiprofloxacinDrug Resistance, BacterialGonorrheaNeisseria gonorrhoeaeAdolescentAdultFemaleGermanyHumansMaleMicrobial Sensitivity TestsMiddle AgedSentinel SurveillanceAnti-Bacterial AgentsAzithromycinCeftriaxoneCiprofloxacinThird Generation CephalosporinsAntimicrobial Drug ResistanceBacterial Sexually Transmitted DiseasesMinimum Inhibitory ConcentrationNeisseria gonorrhoeae InfectionSexual Health

Identifiers

PMID42663072
PMCPMC13525358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.